Since 2020, we have converted over $7,000,000 in one-time revenue to recurring SaaS and increased our recurring revenue from 62% of total revenue to over 98%. John Merrill: We have done this while ...

As I look back on the past year, it is clear that 2025 was one of the most significant and value-creating years in Halozyme Therapeutics, Inc.'s history. This level of execution has created a clear ...

March can be a difficult month for many, as we await all the changes – good and bad – that the financial new year promises to ...

Learn about league tables, their role in ranking companies by financial metrics such as revenue and market share, and explore examples of their use in finance and beyond.